Work

Randomized phase II CTEP study of MK2206 versus everolimus in VEGF inhibitor refractory renal cell carcinoma patients.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.4517

Authors: Eric Jonasch, Paul Gettys Corn, Lance C. Pagliaro, Primo Lara, Xuemei Wang, Kim-Anh Do, Racheal Garza, Shelly Bird, Joseph J. Drabick, Valerie Marcott, David Quinn, Austin Doyle, Nizar M. Tannir

Institutions: The University of Texas MD Anderson Cancer Center, UC Davis Comprehensive Cancer Center, Penn State Cancer Institute, University of Southern California, National Cancer Institute

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2965119882

Cites:

Cited by: 7

Related to: 10